Holen Sie sich die Stockscreener-App
6.97
3.57%
0.24
Schlusskurs vom Vortag:
$6.73
Offen:
$6.74
24-Stunden-Volumen:
3.68M
Relative Volume:
0.88
Marktkapitalisierung:
$1.08B
Einnahmen:
$419.75M
Nettoeinkommen (Verlust:
$-15.10M
KGV:
-73.14
EPS:
-0.0953
Netto-Cashflow:
$63.10M
1W Leistung:
+26.96%
1M Leistung:
+24.02%
6M Leistung:
-20.25%
1J Leistung:
-39.34%
1-Tages-Spanne:
$6.74
$7.055
1-Wochen-Bereich:
$5.41
$7.055
52-Wochen-Spanne:
$4.45
$13.88
Certara Inc Stock (CERT) Company Profile
Firmenname
Certara Inc
Sektor
Branche
Telefon
(415) 237-8272
Adresse
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
Compare CERT vs VEEV, BTSG, TEM, HQY, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CERT
Certara Inc
|
6.97 | 1.02B | 419.75M | -15.10M | 63.10M | -0.0953 |
VEEV
Veeva Systems Inc
|
192.74 | 28.83B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
69.03 | 13.69B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
60.27 | 10.40B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
95.31 | 7.55B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
84.05 | 6.42B | 646.34M | -512.40M | 202.76M | -6.6871 |
Certara Inc Stock (CERT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-06 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2026-02-27 | Herabstufung | Craig Hallum | Buy → Hold |
| 2026-01-06 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-11-21 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-09-29 | Eingeleitet | Craig Hallum | Buy |
| 2025-07-03 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2025-05-08 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-02-27 | Eingeleitet | TD Cowen | Buy |
| 2024-09-27 | Hochstufung | UBS | Neutral → Buy |
| 2024-04-10 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-04 | Eingeleitet | JMP Securities | Mkt Perform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-07 | Eingeleitet | UBS | Neutral |
| 2023-12-05 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2023-08-22 | Herabstufung | Jefferies | Buy → Hold |
| 2023-08-10 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2023-04-03 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-12-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-09-08 | Eingeleitet | Berenberg | Buy |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-07-01 | Eingeleitet | Piper Sandler | Overweight |
| 2022-01-11 | Hochstufung | Jefferies | Hold → Buy |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-07-23 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-06 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-01-05 | Eingeleitet | BofA Securities | Buy |
| 2021-01-05 | Eingeleitet | Credit Suisse | Neutral |
| 2021-01-05 | Eingeleitet | Jefferies | Hold |
| 2021-01-05 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Certara Inc Aktie (CERT) Neueste Nachrichten
Does Certara (CERT) Joining the Russell 2000 Recast Its Biosimulation Investment Narrative? - simplywall.st
Certara Inc (NASDAQ: CERT) Share Price, CERT Stock News, CERT Share Price & Updates - Kalkine
Should You Investigate Certara, Inc. (NASDAQ:CERT) At US$6.36? - Moomoo
Certara, Inc. (CERT) Investigation: Bronstein, Gewirtz & Grossman - The National Law Review
Certara, Inc.(NasdaqGS: CERT) added to Russell 2000 Index - marketscreener.com
Certara, Inc.(NasdaqGS: CERT) dropped from Russell Midcap Value Benchmark - marketscreener.com
Enterprise value to EBITDA forward of Certara, Inc. – NASDAQ:CERT - TradingView
Certara, Inc.(NasdaqGS: CERT) dropped from Russell 1000 Index - marketscreener.com
Enterprise value to EBIT forward of Certara, Inc. – NASDAQ:CERT - TradingView
Price to book forward of Certara, Inc. – NASDAQ:CERT - TradingView
Price to book forward of Certara, Inc. – BMV:CERT - TradingView
Price to earnings forward of Certara, Inc. – BMV:CERT - TradingView
[Latest] Global In Silico Clinical Trials Market Size/Share Worth USD 8.94 Billion by 2035 at a 15.2% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc.CERT - PR Newswire
Certara, Inc. Actuals & Estimates (NASDAQ:CERT) - TradingView
CERT Forecast — Price Target — Prediction for 2027 - TradingView
Certara Q1 2026 Earnings: EPS Misses Estimates Amid Challenging QuarterAnalyst Consensus Shift - dars.gov.et
Certara Launches Bio Venture Catalyst for Emerging Biotechs to De-Risk Investment and Accelerate Development - marketscreener.com
CERT Stock Slides As Certara Faces Probes And CFO Exit - timothysykes.com
Certara StockLaw Firm Launches Investigation After Share Price Slide - AD HOC NEWS
Certara names Faiz Mohammed interim CFO as John Gallagher steps down - MSN
Certara (CERT) Stock Sees Fair Value Edges Lower As Analysts Trim Targets - Yahoo Finance
Bragar Eagel & Squire, P.C. is Investigating Certara, Inc. - GlobeNewswire
(CERT) Volatility Zones as Tactical Triggers - Stock Traders Daily
Certara, Inc. Shareholders Are Encouraged to Reach Out to - GlobeNewswire
Certara Appoints Interim CFO Amid Leadership Transition - The Globe and Mail
Certara CFO John Gallagher to resign, reaffirms 2026 guidance By Investing.com - Investing.com India
SMID Core Equity Portfolio's Certara Inc(CERT) Holding History - GuruFocus
Certara (CERT) CFO John Gallagher Announces Resignation, Interim Successor Appointed - GuruFocus
Certara Announces CFO Transition, Names Interim CFO, and Reaffirms 2026 Financial Guidance - Minichart
Certara (CERT) CFO John Gallagher to Resign in 2026, Interim Suc - GuruFocus
Certara CFO John Gallagher to resign, reaffirms 2026 guidance - Investing.com
Certara Announces CFO Transition - The Manila Times
CFO transition at Certara (NASDAQ: CERT) as company reaffirms 2026 guidance - Stock Titan
Certara, Inc. Announces Executive Changes - marketscreener.com
Certara Inc (CERT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Certara Inc (CERT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Certara Inc (CERT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Certara Inc (CERT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Certara Inc (CERT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Certara Inc (CERT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Certara Inc (CERT) Institutional Confidence - TradingKey
Certara Inc (CERT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Certara Inc (CERT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Certara, Inc. Hits Day High with 16.12% Surge in Stock Price - MarketsMojo
Is It Time To Consider Buying Certara, Inc. (NASDAQ:CERT)? - simplywall.st
symbol__ Stock Quote Price and Forecast - CNN
Certara (CERT) Valuation Boosted by Simulations Plus Acquisition - GuruFocus
Certara outlines AI push, cost cuts and new growth engines at Jefferies conference - MSN
CERT Q1 2026 Earnings: EPS Misses Estimates, Stock DeclinesLong-Term Guidance - dars.gov.et
CERT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Finanzdaten der Certara Inc-Aktie (CERT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Certara Inc-Aktie (CERT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Corcoran Daniel | SVP and General Counsel |
Jun 01 '26 |
Option Exercise |
0.00 |
22,830 |
0 |
39,939 |
| Collins Cynthia | Director |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
51,846 |
| Reynders John V W | Chief Financial Officer |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
26,466 |
| BROSHY ERAN | Chairman |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
50,708 |
| Bedi Arjun | Director |
May 14 '26 |
Option Exercise |
0.00 |
5,547 |
0 |
5,547 |
| CASHMAN JAMES E III | Chairman |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
484,197 |
| Killefer Nancy | Director |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
51,846 |
| Crane Rosemary A | Director |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
45,672 |
| WALSH MATTHEW M | Director |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
213,316 |
| Resnick Jon Matthew | Chief Executive Officer |
May 11 '26 |
Option Exercise |
0.00 |
59,766 |
0 |
59,766 |
1.79%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):